title: Prognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: a prospective study.
abstract: In survivors of complicated myocardial infarction, the inducibility of sustained ventricular tachycardia may help identify a subset that is at increased risk for subsequent sudden cardiac death or spontaneous sustained ventricular tachycardia. We performed prehospital discharge programmed ventricular stimulation in 86 survivors of acute myocardial infarction complicated by heart failure, angina pectoris, or nonsustained ventricular tachycardia. These patients also underwent cardiac catheterization with coronary angiography and 24-hour ambulatory ECG recording. Programmed ventricular stimulation induced sustained ventricular tachycardia in 19 patients (22%) and ventricular fibrillation in six (7%) and did not induce these arrhythmias in 61 patients (71%). During an average follow-up of 18 +/- 13 months, 11 patients had arrhythmic events (seven sudden death and four nonfatal spontaneous sustained ventricular tachycardia) and 10 patients had nonsudden cardiac death. The total cardiac mortality rate was 20%. Arrhythmic events occurred in 32% of the 19 patients with inducible sustained ventricular tachycardia compared with 7% of the remaining 67 patients (p less than 0.003). By multivariate analysis the occurrence of arrhythmic events was independently predicted by both inducible sustained ventricular tachycardia and Killip class III or IV heart failure. The risk of arrhythmic events was 4.4% in the absence of both variables versus 38.4% (p less than 0.001) when both variables were present. The total cardiac mortality rate was best predicted by low left ventricular ejection fraction (less than 30%). Thus programmed ventricular stimulation is useful in risk stratification of survivors of complicated acute myocardial infarction. The prognostic utility appears to be particularly high in patients with infarction complicated by Killip class III or IV heart failure.
authors.affiliation: Department of Medicine, Los Angeles County/University of Southern California Medical Center.
authors.forename: A K
authors.initials: AK
authors.lastname: Bhandari
authors.forename: J
authors.initials: J
authors.lastname: Widerhorn
authors.forename: P T
authors.initials: PT
authors.lastname: Sager
authors.forename: C
authors.initials: C
authors.lastname: Leon
authors.forename: R
authors.initials: R
authors.lastname: Hong
authors.forename: A
authors.initials: A
authors.lastname: Kotlewski
authors.forename: J
authors.initials: J
authors.lastname: Hackett
authors.forename: S H
authors.initials: SH
authors.lastname: Rahimtoola
mesh_terms: D001145:Arrhythmias, Cardiac / Q000453:epidemiology*; D002304:Cardiac Pacing, Artificial; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality*; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013610:Tachycardia / Q000453:epidemiology*; D013997:Time Factors